Health Care

The Belarusian Interior Ministry has launched a criminal probe against Russia's food safety officials, the latest move in an escalating spat between the two ex-Soviet neighbors and allies.

Activist investor Starboard Value has grabbed several seats on the board of Perrigo, months after saying it would push the drugmaker to its improve operations.

The Republican leader of the U.S. House of Representatives said on Tuesday that legislation to replace former President Barack Obama's signature healthcare law will be completed this year, although it may take longer to implement.

One in ten babies are born premature (before term, 37 weeks), reports the March of Dimes.

Japanese automakers Toyota and Suzuki, which began looking into a partnership in October, say they have decided to work together in ecological and safety technology — a rapidly growing area in the industry.

Forget New Year’s Day, the new diet start date—for men —is the day after the Super Bowl, according to big diet companies.

President Donald Trump downgraded expectations for his party's swift repeal and replacement of the 2010 health law in a Sunday interview with Fox News' Bill O'Reilly, saying "maybe it'll take til some time into next year"

Belarusian President Alexander Lukashenko in a televised outburst has asked the country's interior minister to press charges against Russia's top food safety official.

A woman is facing charges for allegedly using dirt to contaminate chicken while working at a Minnesota processing plant.

Several lines of dressers are being recalled because they pose a tip-over hazard.

You might not want to open a rear window if you're driving a Nissan Altima.

Some varieties of Skoal, Copenhagen, Cope and Husky brand smokeless tobacco are being voluntarily recalled amid complaints of metal objects, some of them sharp, being spotted in cans.

Merck's quarterly revenue narrowly missed Wall Street expectations, hurt by lower-than-expected sales of its key immuno-oncology drug, Keytruda, and its diabetes medicines.

Merck & Co.'s new cancer medicine Keytruda, a blockbuster nearly overnight, along with aggressive and ongoing cost cuts, helped to boost fourth-quarter profits by 21 percent.

Cigna, which is awaiting a ruling on the U.S. government's lawsuit to block its acquisition by Anthem, reported a better-than-expected quarterly profit, helped by strength in its commercial business.

Every minute, a woman dies from heart disease in the United States – and many of them never see it coming, which the American Heart Association (AHA) says could make a life-saving difference.

Anglo-Swedish drugmaker AstraZeneca says fourth-quarter revenue fell 13 percent after the cholesterol treatment Crestor lost patent protection in the United States.